Deepika Pakianathan, Director, 10% Owner at ALDER BIOPHARMACEUTICALS INC (ALDR), bought 2,813,894 shares at $10.00 ($3.5M) on 2014-05-13, disclosed to the SEC on 2014-05-15.
Open-market purchase of $3.5M ALDR by Director, 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 2,463,894 | $0 | 0.0% |
| 2 | $10.00 | 3,465 | $35K | 1.0% |
| 3 | $10.00 | 346,535 | $3.5M | 99.0% |
| Total | $1.24 avg | 2,813,894 | $3.5M | 100% |
| Filing → |
| KPTI | SELL | 2024-06-04 | $1.4M | — | Filing → |
| CALA | SELL | 2023-01-31 | $47K | — | Filing → |
| KPTI | SELL | 2022-06-10 | $6.8M | — | Filing → |